People and recognition

Vidi grants for Erik Garnett and Yves Rezus

AMOLF group leaders Erik Garnett and Yves Rezus have received an NWO Vidi grant. NWO has awarded 87 experienced researchers a Vidi grant worth 800,000 euros. The grant enables them to develop their own innovative line of research.

Research summary:

Yves Rezus Biomolecular Photonics
How to keep a healthy shape
Prion diseases, such as Creutzfeldt-Jakob and mad-cow disease, are dangerous neurodegenerative disorders caused by the misfolding and aggregation of the protein PrP. This protein causes a deadly chain reaction in the brain because, when it misfolds, it stimulates the misfolding and aggregation of healthy copies of PrP. We will use advanced laser-spectroscopic techniques to study the molecular mechanism underlying these diseases. Understanding this mechanism is important as it will provide an insight into possible treatments.

Erik Garnett Nanoscale Solar Cells
NanoBricks: Building monocrystalline optoelectronics from welded nanocubes
In order to reach a high conversion efficiency, solar cells must be made from perfect crystals with a specific shape.  Today, this is typically accomplished by starting with a large crystal and cutting it into the preferred form, which wastes material and damages the surface. The NanoBricks program will take an entirely different approach, building up perfect crystals with the desired shape by assembling and welding together nanocubes.

Share article
What's happening

Most recent news items

All news items
Collaboration

Successful outcomes of international EBEAM program led by AMOLF

The EU Pathfinder project Electron Beams Enhancing Analytical Microscopy (EBEAM) that was recently completed has received a highly positive review of the European Innovation Council (EIC). EBEAM brought together eight European research institutions and companies, including AMOLF, that develop new concepts and instruments combining spectroscopic analysis with electron microscopy.

Read news item
Research highlights

Everything you need to know about organoids

Organoids are instrumental in improving our understanding of processes that are otherwise hidden inside the body. For instance, these small 3D organs can be used to test medicines on tissue grown from a patient’s own cells. AMOLF researchers carry out unique and complex experiments to follow organoids in time. In order to enable other researchers to benefit from their experiences, they now publish their methods in the prestigious journal Nature Protocols.

Read news item
Events and outreach

Minister Rianne Letschert wears hat and shoulder ornament inspired by Wim Noorduin’s research

This year at the opening of the parliamentary year (Prinsjesdag) Minister of Education, Culture and Science Rianne Letschert wears a spectacular hat and shoulder ornament. Both of them are inspired by the microscopic structures studied by group leader Wim Noorduin (AMOLF/UvA), which look remarkably like tiny flowers under a microscope. Artist and designer Malou Beemer translated these shapes, normally invisible to the naked eye, into wearable art.

Read news item
Nachi Stern, Group Leader Learning Machines at AMOLF
People and recognition

Nachi Stern awarded ERC Starting Grant to explore how matter learns

Why do brains learn, but rocks do not? Could a material one day adapt to its environment the way a living organism does? AMOLF group leader Dr. Nachi Stern has been awarded an ERC Starting Grant to investigate the physical laws of learning, in a project called, “Physical Learning in Dynamical Systems.”

Read news item
Stay informed

Get the latest research highlights, events, and news from our institute delivered to your inbox